nodes	percent_of_prediction	percent_of_DWPC	metapath
Flucloxacillin—Arthralgia—Azathioprine—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Flucloxacillin—Myalgia—Azathioprine—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Flucloxacillin—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Flucloxacillin—Leukopenia—Leflunomide—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Flucloxacillin—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Flucloxacillin—Abdominal pain—Mometasone—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Flucloxacillin—Body temperature increased—Mometasone—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Flucloxacillin—Discomfort—Azathioprine—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Flucloxacillin—Anaemia—Mycophenolic acid—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Flucloxacillin—Purpura—Prednisone—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Flucloxacillin—Dyspepsia—Captopril—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Flucloxacillin—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Flucloxacillin—Dizziness—Pentoxifylline—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Flucloxacillin—Decreased appetite—Captopril—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Flucloxacillin—Malaise—Mycophenolic acid—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Flucloxacillin—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Flucloxacillin—Myalgia—Leflunomide—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Flucloxacillin—Arthralgia—Leflunomide—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Flucloxacillin—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Flucloxacillin—Constipation—Captopril—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Flucloxacillin—Dysgeusia—Lisinopril—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Flucloxacillin—Discomfort—Leflunomide—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Flucloxacillin—Skin disorder—Azathioprine—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Flucloxacillin—Vomiting—Pentoxifylline—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Flucloxacillin—Convulsion—Mycophenolic acid—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Flucloxacillin—Rash—Pentoxifylline—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Flucloxacillin—Dermatitis—Pentoxifylline—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Flucloxacillin—Headache—Pentoxifylline—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Flucloxacillin—Feeling abnormal—Captopril—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Flucloxacillin—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Flucloxacillin—Myalgia—Mycophenolic acid—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Captopril—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Flucloxacillin—Discomfort—Mycophenolic acid—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Flucloxacillin—Nervous system disorder—Leflunomide—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Lisinopril—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Flucloxacillin—Anaemia—Lisinopril—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Flucloxacillin—Skin disorder—Leflunomide—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Flucloxacillin—Angioedema—Lisinopril—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Flucloxacillin—Abdominal pain—Captopril—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Flucloxacillin—Body temperature increased—Captopril—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Flucloxacillin—Nausea—Pentoxifylline—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Flucloxacillin—Malaise—Lisinopril—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Flucloxacillin—Diarrhoea—Mometasone—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Flucloxacillin—Leukopenia—Lisinopril—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Flucloxacillin—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Flucloxacillin—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Flucloxacillin—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Flucloxacillin—Arthralgia—Lisinopril—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Flucloxacillin—Myalgia—Lisinopril—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Flucloxacillin—Discomfort—Lisinopril—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Flucloxacillin—Dyspepsia—Leflunomide—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Flucloxacillin—Vomiting—Mometasone—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Flucloxacillin—Feeling abnormal—Azathioprine—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Flucloxacillin—Rash—Mometasone—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Flucloxacillin—Dermatitis—Mometasone—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Flucloxacillin—Decreased appetite—Leflunomide—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Flucloxacillin—Headache—Mometasone—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Flucloxacillin—Constipation—Leflunomide—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Flucloxacillin—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Flucloxacillin—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Flucloxacillin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Flucloxacillin—Neutropenia—Prednisone—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Flucloxacillin—Abdominal pain—Azathioprine—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Flucloxacillin—Body temperature increased—Azathioprine—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Flucloxacillin—Skin disorder—Lisinopril—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Flucloxacillin—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Flucloxacillin—Diarrhoea—Captopril—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Flucloxacillin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Flucloxacillin—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Flucloxacillin—Feeling abnormal—Leflunomide—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Flucloxacillin—Nausea—Mometasone—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Flucloxacillin—Constipation—Mycophenolic acid—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Flucloxacillin—Dizziness—Captopril—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Flucloxacillin—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Flucloxacillin—Urticaria—Leflunomide—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Flucloxacillin—Abdominal pain—Leflunomide—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Flucloxacillin—Body temperature increased—Leflunomide—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Flucloxacillin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Flucloxacillin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Flucloxacillin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Flucloxacillin—Hypersensitivity—Azathioprine—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Flucloxacillin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Flucloxacillin—Vomiting—Captopril—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Flucloxacillin—Rash—Captopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Flucloxacillin—Dermatitis—Captopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Flucloxacillin—Headache—Captopril—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Flucloxacillin—Dyspepsia—Lisinopril—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Flucloxacillin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Flucloxacillin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Flucloxacillin—Decreased appetite—Lisinopril—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Flucloxacillin—Eosinophilia—Methotrexate—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Flucloxacillin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Flucloxacillin—Hypersensitivity—Leflunomide—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Flucloxacillin—Constipation—Lisinopril—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Flucloxacillin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Flucloxacillin—Diarrhoea—Azathioprine—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Flucloxacillin—Nausea—Captopril—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Flucloxacillin—Feeling abnormal—Lisinopril—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Prednisone—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Flucloxacillin—Neutropenia—Methotrexate—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Flucloxacillin—Dizziness—Azathioprine—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Flucloxacillin—Diarrhoea—Leflunomide—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Flucloxacillin—Urticaria—Lisinopril—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Flucloxacillin—Body temperature increased—Lisinopril—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Flucloxacillin—Abdominal pain—Lisinopril—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Flucloxacillin—Vomiting—Azathioprine—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Flucloxacillin—Rash—Azathioprine—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Flucloxacillin—Dermatitis—Azathioprine—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Flucloxacillin—Headache—Azathioprine—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Flucloxacillin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Flucloxacillin—Dizziness—Leflunomide—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Flucloxacillin—Renal failure—Methotrexate—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Flucloxacillin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Flucloxacillin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Flucloxacillin—Immune system disorder—Prednisone—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Flucloxacillin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Flucloxacillin—Haematuria—Methotrexate—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Flucloxacillin—Vomiting—Leflunomide—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Flucloxacillin—Hypersensitivity—Lisinopril—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Flucloxacillin—Dizziness—Mycophenolic acid—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Flucloxacillin—Rash—Leflunomide—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Flucloxacillin—Dermatitis—Leflunomide—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Flucloxacillin—Nausea—Azathioprine—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Flucloxacillin—Headache—Leflunomide—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Flucloxacillin—Agranulocytosis—Methotrexate—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Flucloxacillin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Flucloxacillin—Vomiting—Mycophenolic acid—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Flucloxacillin—Rash—Mycophenolic acid—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Flucloxacillin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Flucloxacillin—Hepatitis—Methotrexate—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Flucloxacillin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Flucloxacillin—Headache—Mycophenolic acid—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Flucloxacillin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Flucloxacillin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Flucloxacillin—Nausea—Leflunomide—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Methotrexate—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Flucloxacillin—Urethral disorder—Methotrexate—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Flucloxacillin—Diarrhoea—Lisinopril—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Prednisone—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Flucloxacillin—Anaemia—Prednisone—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Flucloxacillin—Angioedema—Prednisone—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Flucloxacillin—Dizziness—Lisinopril—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Flucloxacillin—Erythema multiforme—Methotrexate—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Flucloxacillin—Nausea—Mycophenolic acid—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Flucloxacillin—Malaise—Prednisone—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Flucloxacillin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000992	0.000992	CcSEcCtD
Flucloxacillin—Vomiting—Lisinopril—systemic scleroderma	0.000977	0.000977	CcSEcCtD
Flucloxacillin—Immune system disorder—Methotrexate—systemic scleroderma	0.00097	0.00097	CcSEcCtD
Flucloxacillin—Rash—Lisinopril—systemic scleroderma	0.000969	0.000969	CcSEcCtD
Flucloxacillin—Convulsion—Prednisone—systemic scleroderma	0.000969	0.000969	CcSEcCtD
Flucloxacillin—Dermatitis—Lisinopril—systemic scleroderma	0.000968	0.000968	CcSEcCtD
Flucloxacillin—Headache—Lisinopril—systemic scleroderma	0.000963	0.000963	CcSEcCtD
Flucloxacillin—Myalgia—Prednisone—systemic scleroderma	0.000952	0.000952	CcSEcCtD
Flucloxacillin—Arthralgia—Prednisone—systemic scleroderma	0.000952	0.000952	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000946	0.000946	CcSEcCtD
Flucloxacillin—Discomfort—Prednisone—systemic scleroderma	0.000941	0.000941	CcSEcCtD
Flucloxacillin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000921	0.000921	CcSEcCtD
Flucloxacillin—Dysgeusia—Methotrexate—systemic scleroderma	0.000915	0.000915	CcSEcCtD
Flucloxacillin—Nausea—Lisinopril—systemic scleroderma	0.000913	0.000913	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000913	0.000913	CcSEcCtD
Flucloxacillin—Nervous system disorder—Prednisone—systemic scleroderma	0.000895	0.000895	CcSEcCtD
Flucloxacillin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000891	0.000891	CcSEcCtD
Flucloxacillin—Skin disorder—Prednisone—systemic scleroderma	0.000887	0.000887	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000867	0.000867	CcSEcCtD
Flucloxacillin—Anaemia—Methotrexate—systemic scleroderma	0.000864	0.000864	CcSEcCtD
Flucloxacillin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000856	0.000856	CcSEcCtD
Flucloxacillin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000849	0.000849	CcSEcCtD
Flucloxacillin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000848	0.000848	CcSEcCtD
Flucloxacillin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000844	0.000844	CcSEcCtD
Flucloxacillin—Malaise—Methotrexate—systemic scleroderma	0.000843	0.000843	CcSEcCtD
Flucloxacillin—Leukopenia—Methotrexate—systemic scleroderma	0.000837	0.000837	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000832	0.000832	CcSEcCtD
Flucloxacillin—Convulsion—Methotrexate—systemic scleroderma	0.00081	0.00081	CcSEcCtD
Flucloxacillin—Dyspepsia—Prednisone—systemic scleroderma	0.000804	0.000804	CcSEcCtD
Flucloxacillin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.0008	0.0008	CcSEcCtD
Flucloxacillin—Myalgia—Methotrexate—systemic scleroderma	0.000796	0.000796	CcSEcCtD
Flucloxacillin—Arthralgia—Methotrexate—systemic scleroderma	0.000796	0.000796	CcSEcCtD
Flucloxacillin—Decreased appetite—Prednisone—systemic scleroderma	0.000794	0.000794	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.00079	0.00079	CcSEcCtD
Flucloxacillin—Discomfort—Methotrexate—systemic scleroderma	0.000786	0.000786	CcSEcCtD
Flucloxacillin—Constipation—Prednisone—systemic scleroderma	0.000781	0.000781	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000763	0.000763	CcSEcCtD
Flucloxacillin—Feeling abnormal—Prednisone—systemic scleroderma	0.000752	0.000752	CcSEcCtD
Flucloxacillin—Nervous system disorder—Methotrexate—systemic scleroderma	0.000748	0.000748	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000747	0.000747	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000746	0.000746	CcSEcCtD
Flucloxacillin—Skin disorder—Methotrexate—systemic scleroderma	0.000741	0.000741	CcSEcCtD
Flucloxacillin—Urticaria—Prednisone—systemic scleroderma	0.000725	0.000725	CcSEcCtD
Flucloxacillin—Abdominal pain—Prednisone—systemic scleroderma	0.000722	0.000722	CcSEcCtD
Flucloxacillin—Body temperature increased—Prednisone—systemic scleroderma	0.000722	0.000722	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000695	0.000695	CcSEcCtD
Flucloxacillin—Hypersensitivity—Prednisone—systemic scleroderma	0.000673	0.000673	CcSEcCtD
Flucloxacillin—Dyspepsia—Methotrexate—systemic scleroderma	0.000672	0.000672	CcSEcCtD
Flucloxacillin—Decreased appetite—Methotrexate—systemic scleroderma	0.000663	0.000663	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000659	0.000659	CcSEcCtD
Flucloxacillin—Feeling abnormal—Methotrexate—systemic scleroderma	0.000629	0.000629	CcSEcCtD
Flucloxacillin—Diarrhoea—Prednisone—systemic scleroderma	0.000625	0.000625	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000624	0.000624	CcSEcCtD
Flucloxacillin—Urticaria—Methotrexate—systemic scleroderma	0.000606	0.000606	CcSEcCtD
Flucloxacillin—Dizziness—Prednisone—systemic scleroderma	0.000604	0.000604	CcSEcCtD
Flucloxacillin—Abdominal pain—Methotrexate—systemic scleroderma	0.000603	0.000603	CcSEcCtD
Flucloxacillin—Body temperature increased—Methotrexate—systemic scleroderma	0.000603	0.000603	CcSEcCtD
Flucloxacillin—Vomiting—Prednisone—systemic scleroderma	0.00058	0.00058	CcSEcCtD
Flucloxacillin—Rash—Prednisone—systemic scleroderma	0.000576	0.000576	CcSEcCtD
Flucloxacillin—Dermatitis—Prednisone—systemic scleroderma	0.000575	0.000575	CcSEcCtD
Flucloxacillin—Headache—Prednisone—systemic scleroderma	0.000572	0.000572	CcSEcCtD
Flucloxacillin—Hypersensitivity—Methotrexate—systemic scleroderma	0.000562	0.000562	CcSEcCtD
Flucloxacillin—Nausea—Prednisone—systemic scleroderma	0.000542	0.000542	CcSEcCtD
Flucloxacillin—Diarrhoea—Methotrexate—systemic scleroderma	0.000522	0.000522	CcSEcCtD
Flucloxacillin—Dizziness—Methotrexate—systemic scleroderma	0.000505	0.000505	CcSEcCtD
Flucloxacillin—Vomiting—Methotrexate—systemic scleroderma	0.000485	0.000485	CcSEcCtD
Flucloxacillin—Rash—Methotrexate—systemic scleroderma	0.000481	0.000481	CcSEcCtD
Flucloxacillin—Dermatitis—Methotrexate—systemic scleroderma	0.000481	0.000481	CcSEcCtD
Flucloxacillin—Headache—Methotrexate—systemic scleroderma	0.000478	0.000478	CcSEcCtD
Flucloxacillin—Nausea—Methotrexate—systemic scleroderma	0.000453	0.000453	CcSEcCtD
